![Andrew Aromando](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Aromando
Director de Operaciones en AMBRX INC .
Cargos activos de Andrew Aromando
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AMBRX INC | Director de Operaciones | 01/04/2023 | - |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Director de Operaciones | 28/04/2023 | - |
Historial de carrera de Andrew Aromando
Antiguos cargos conocidos de Andrew Aromando.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Innovex LP
![]() Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC. | Corporate Officer/Principal | 01/01/2000 | 01/01/2004 |
Tamir Biotechnology, Inc.
![]() Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Director de Operaciones | - | - |
Formación de Andrew Aromando.
The College of New Jersey | Undergraduate Degree |
Rutgers State University of New Jersey | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Francia | 2 |
Operativa
Chief Operating Officer | 4 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Tamir Biotechnology, Inc.
![]() Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
Innovex LP
![]() Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC. | Commercial Services |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx, Inc.
![]() Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Aromando
- Experiencia